The rs182052 polymorphism is positioned at the adiponectin gene (ADIPOQ) promoter region, and is associated with adiponectin levels as well as risks of a variety of cancers [16–22], such as prostate, colorectal, breast, and kidney cancer. Here, ADIPOQ is linked to kidney cancer.